Haematology

Current Clinical Trials

Protocol Name / No.	Protocol Title	Principal Investigator
AC220-168	A Phase 3, Double-Blind, Placebo-Controlled Study of Quizartinib Administered in Combination with Induction and Consolidation Chemotherapy, and Administered as Maintenance Therapy in Adult Patients with Newly Diagnosed FLT3-ITD (-) Acute Myeloid Leukemia NCT number: https://clinicaltrials.gov/study/NCT06578247	Dr Yvonne Loh